About rimonabant
Cannabinoid receptor type 1 blocker
Used for
- Previously used for weight management in adults with obesity or overweight and related risk factors; withdrawn from sale.
Usual adult dose
Previously 20 mg once daily; no longer marketed in many countries.
Common side effects
- Depression
- Anxiety
- Insomnia
- Nausea
Important warnings
- Withdrawn or suspended in many countries because of serious psychiatric risks.
- Can cause depression and suicidal thoughts or behavior.
- Avoid in people with current or previous major depression or suicidal thoughts.
Pregnancy
Not recommended; weight-loss treatment offers no benefit during pregnancy.
Breastfeeding
Use is not recommended; safety information is insufficient.
Interactions
- Antidepressants and other medicines affecting mood may increase psychiatric concerns.
- Strong CYP3A4 inhibitors can increase rimonabant exposure.
- CYP3A4 inducers may reduce rimonabant exposure.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.